These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
83 related items for PubMed ID: 9843026
1. Identification of melanoma metastases by tyrosinase-reverse transcription-polymerase chain reaction of fine needle aspirates. Voit C, Schoengen A, Weber L, Proebstle T. J Am Acad Dermatol; 1998 Dec; 39(6):1030-2. PubMed ID: 9843026 [No Abstract] [Full Text] [Related]
2. Molecular staging of melanoma. Shivers SC, Li W, Haddad F, Reintgen DS. Ann Surg Oncol; 1999 Dec; 6(3):225-6. PubMed ID: 10340877 [No Abstract] [Full Text] [Related]
3. Prognostic significance of molecular staging study of sentinel lymph nodes by reverse transcriptase-polymerase chain reaction for tyrosinase in melanoma patients. Mangas C, Hilari JM, Paradelo C, Rex J, Fernández-Figueras MT, Fraile M, Alastrue A, Ferrándiz C. Ann Surg Oncol; 2006 Jul; 13(7):910-8. PubMed ID: 16788751 [Abstract] [Full Text] [Related]
4. Tyrosinase RT-PCR as a supplement to histology for detecting melanoma and nevus cells in paraffin sections of sentinel lymph nodes. Starz H, Haas CJ, Schulz GM, Balda BR. Mod Pathol; 2003 Sep; 16(9):920-9. PubMed ID: 13679456 [Abstract] [Full Text] [Related]
5. [Detection of tyrosinase mRNA using reverse transcription/polymerase chain reaction with fine needle punctures of melanoma metastases]. Hofmann S, Remy W, Borelli S, von Reis A, Weidinger S. Hautarzt; 1996 Mar; 47(3):197-9. PubMed ID: 8647702 [Abstract] [Full Text] [Related]
6. Impact of molecular staging methods in primary melanoma: reverse-transcriptase polymerase chain reaction (RT-PCR) of ultrasound-guided aspirate of the sentinel node does not improve diagnostic accuracy, but RT-PCR of peripheral blood does predict survival. Voit CA, Schäfer-Hesterberg G, Kron M, van Akkooi AC, Rademaker J, Lukowsky A, Schoengen A, Schwürzer-Voit M, Sterry W, Krause M, Röwert-Huber J, Eggermont AM. J Clin Oncol; 2008 Dec 10; 26(35):5742-7. PubMed ID: 18981467 [Abstract] [Full Text] [Related]
7. Peripheral blood tyrosinase messenger RNA detection and survival in malignant melanoma. Kunter U, Buer J, Probst M, Duensing S, Dallmann I, Grosse J, Kirchner H, Schluepen EM, Volkenandt M, Ganser A, Atzpodien J. J Natl Cancer Inst; 1996 May 01; 88(9):590-4. PubMed ID: 8609659 [Abstract] [Full Text] [Related]
8. No correlation of tyrosinase mRNA in bone marrow with prognosis of metastatic melanoma. Waldmann V, Wacker J, Deichmann M, Näher H. Dermatology; 2000 May 01; 201(1):6-9. PubMed ID: 10971051 [Abstract] [Full Text] [Related]
17. The value of reverse transcription-polymerase chain reaction in malignant melanoma. Russell-Jones R. Br J Dermatol; 2001 Aug 01; 145(2):193-4. PubMed ID: 11531778 [No Abstract] [Full Text] [Related]
18. Detection of regional melanoma metastases by ultrasound B-scan, cytology or tyrosinase RT-PCR of fine-needle aspirates. Voit C, Schoengen A, Schwürzer M, Weber L, Mayer T, Proebstle TM. Br J Cancer; 1999 Jul 01; 80(10):1672-7. PubMed ID: 10408417 [Abstract] [Full Text] [Related]
19. Tyrosinase activity in the serum of patients with malignant melanoma. Sonesson B, Eide S, Ringborg U, Rorsman H, Rosengren E. Melanoma Res; 1995 Apr 01; 5(2):113-6. PubMed ID: 7620338 [Abstract] [Full Text] [Related]
20. Identification of lymph node metastases by use of polymerase chain reaction (PCR) in melanoma patients. Schwürzer-Voit M, Proebstle TM, Sterry W. Eur J Cancer; 1996 Feb 01; 32A(2):264-8. PubMed ID: 8664039 [Abstract] [Full Text] [Related] Page: [Next] [New Search]